It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Clinical impact of fine particulate matter (PM2.5) air pollution on incident atrial fibrillation (AF) had not been well studied. We used integrated machine learning (ML) to build several incident AF prediction models that include average hourly measurements of PM2.5 for the 432,587 subjects of Korean general population. We compared these incident AF prediction models using c-index, net reclassification improvement index (NRI), and integrated discrimination improvement index (IDI). ML using the boosted ensemble method exhibited a higher c-index (0.845 [0.837–0.853]) than existing traditional regression models using CHA2DS2-VASc (0.654 [0.646–0.661]), CHADS2 (0.652 [0.646–0.657]), or HATCH (0.669 [0.661–0.676]) scores (each p < 0.001) for predicting incident AF. As feature selection algorithms identified PM2.5 as a highly important variable, we applied PM2.5 for predicting incident AF and constructed scoring systems. The prediction performances significantly increased compared with models without PM2.5 (c-indices: boosted ensemble ML, 0.954 [0.949–0.959]; PM-CHA2DS2-VASc, 0.859 [0.848–0.870]; PM-CHADS2, 0.823 [0.810–0.836]; or PM-HATCH score, 0.849 [0.837–0.860]; each interaction, p < 0.001; NRI and IDI were also positive). ML combining readily available clinical variables and PM2.5 data was found to predict incident AF better than models without PM2.5 or even established risk prediction approaches in the general population exposed to high air pollution levels.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Yonsei University College of Medicine, Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Seoul, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); Yonsei University College of Medicine, Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
2 CHA University, Department of Cardiology, CHA Bundang Medical Center, Seongnam, Republic of Korea (GRID:grid.410886.3) (ISNI:0000 0004 0647 3511)
3 Yonsei University College of Medicine, Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Seoul, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
4 Ajou University School of Medicine, Department of Biomedical Informatics, Suwon-si, Republic of Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933)
5 Yonsei University College of Medicine, Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)